# First Multi-Facility Antimicrobial Surveillance in Japanese Hospital Wastewater Reveals Spatiotemporal Trends and Source-Specific Environmental Loads

**Authors:** Takashi Azuma, Ai Tsukada, Naoki Fujii, Miwa Katagiri, Itaru Nakamura, Hidefumi Shimizu, Keita Tatsuno, Manabu Watanabe, Norio Ohmagari, Nobuaki Matsunaga

PMC · DOI: 10.3390/antibiotics15010050 · Antibiotics · 2026-01-03

## TL;DR

This study analyzed antimicrobial levels in hospital wastewater in Japan, finding higher concentrations in hospitals and identifying patterns linked to local prescribing practices.

## Contribution

The first multi-facility surveillance of antimicrobial discharge in Japanese hospital wastewater, revealing spatiotemporal trends and source-specific environmental loads.

## Key findings

- Hospital effluents showed consistently higher concentrations of antimicrobials like levofloxacin, vancomycin, and ampicillin compared to non-clinical sites.
- Facility-specific and temporal patterns were observed, indicating links between local prescribing practices and effluent composition.
- Some antimicrobials, such as clarithromycin and minocycline, showed contributions from both hospital and commercial sources.

## Abstract

Background: Hospitals are recognized as point sources of antimicrobials in urban wastewater systems; however, comprehensive evaluations of their discharge profiles have not yet been conducted. Methods: This study presents a multi-site investigation of residual antimicrobial concentrations in effluents from five general hospitals and a commercial facility in the metropolitan area of Japan. Over a 12-week period (December 2023–March 2024), extensive sampling was conducted. Fifteen antimicrobials from multiple classes were quantified using high-throughput analysis. Results: The results revealed consistently higher concentrations in hospital effluents, particularly for levofloxacin, vancomycin, and ampicillin, than in non-clinical sites. Distinct facility-specific and temporal patterns suggest strong links between local prescribing practices and the effluent composition. Some compounds, such as clarithromycin and minocycline, showed dual contributions from both hospital and commercial sources. Conclusions: These findings highlight the need for source-targeted monitoring and antimicrobial pollution control strategies and provide a foundation for expanding surveillance efforts and informing environmental policies related to antimicrobial resistance (AMR).

## Linked entities

- **Chemicals:** levofloxacin (PubChem CID 149096), vancomycin (PubChem CID 14969), ampicillin (PubChem CID 6249), clarithromycin (PubChem CID 84029), minocycline (PubChem CID 54675783)

## Full-text entities

- **Chemicals:** clarithromycin (MESH:D017291), minocycline (MESH:D008911), ampicillin (MESH:D000667), vancomycin (MESH:D014640), levofloxacin (MESH:D064704)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12837197/full.md

## Figures

22 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12837197/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12837197/full.md

---
Source: https://tomesphere.com/paper/PMC12837197